oral glp-1 drugs in development What is the pipeline for future medications for obesity? GLP-1 Oral Solution – Affordable
Description
Nystrm T, Gonon AT, Sjholm A, Pernow J
Read it here: Can I say, I told ya
The study made headlines at the 2026 American Society of Clinical Oncology (ASCO) annual meeting in June
Semaglutide is a peptide that belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs
Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats
Available evidence suggests semaglutide and tirzepatide, if present in breast milk, appear at very low levels
